Publication: Patents:
- Adaptive Foundation AI Architecture for Real-Time Oncology Digital Twins and Predictive Precision Cancer care Therapeutics", Patent Application No. 20264106760, published on 2026.
- AI-Powered Multi-Analyte Liquid Biopsy Platform for Early Cancer Detection, Molecular Profiling and Predictive Oncology Intelligence", Patent Application No. 20264106761, published on 2026.
- Adaptive Immuno-Oncology Foundation Model for Predicting Immune Escape, Therapeutic Resistance and Treatment Response Dynamics", Patent Application No. 20264106764, published on 2026.
Books:
- AI-Driven Liquid Biopsy Systems for Early Cancer Detection ISBN: 979-8-950819-09-4.
- Digital Twin Oncology: AI-Driven Predictive and Personalized Cancer Care ISBN: 979-8-950819-12-4.
Publications:
- Integrated Transcriptomic and Machine Learning Framework Identifies a Blood-Based Biomarker Signature for Anthracycline-Induced Cardiotoxicity in Juvenile Cancer Survivors.
- AI-Driven Liquid Biopsy Systems for Early Cancer Detection and Personalized Oncology.
- Precision Oncofertility: Integrating Genomics, Reproductive Biomarkers, Treatment Toxicity Profiles, and Foundation Models for Fertility Preservation in Men and Women with Cancer.
- 3. Self-Evolving Digital Twin Ecosystems for Early Detection and Precision Management of Breast, Lung, Colorectal, and Ovarian Cancers.
- Pan-System Cancer Intelligence: Integrating Blood, Immune, Microbiome, and Tumor Microenvironment Data Using Foundation Models.
|
International Journal of Science, Engineering and Technology